This federal contract award is for the delivery of Mirena 52 mg Systems, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois.
The award is a delivery order under the SPE2DB program, which is a larger Indefinite Delivery Contract (IDC) with a ceiling value of $499,999,999 held by DMS Pharmaceutical Group Inc. The current delivery order has a ceiling value of $3,552 and a firm fixed-price pricing type. The contract does not have a set-aside designation. The award date is December 18, 2024, and the ultimate completion date is January 10, 2025.
Generated 3/23/25, 1:01 AM